In his first regular column for GOLD, Davidek Herron discusses digital transformation in pharma and pursuing operational excellence.

With opioid abuse showing little sign of abating, what role can pharma play in addressing the crisis?

PRESENTED in a hybrid format for the first time, this year’s European Respiratory Society (ERS) International Congress welcomed over 19,000 respiratory professionals, with over 10,000 attending in-person in Barcelona, Spain. Known for its stunning buildings, Barcelona is home to many unusual architectural wonders, including Antoni Gaudí’s Casa Batlló, which was classified as a UNESCO World Heritage Site in 2005.

The authors present a study that investigated the clinical features and therapy of superior sulcus1-3 non-small cell lung cancer during a 22-year period. There was a review of 100 patients who underwent curative surgery for superior sulcus non-small cell lung cancer during a 22-year period (July 1998 to December 2020). Patients with an apical tumour and Pancoast syndrome, superior sulcus tumours with invasion of the chest wall, vertebral body, and/or subclavian arteries met the inclusion criteria.

Stolz explained that complex cases of ILD that are difficult to diagnose are often encountered in a tertiary care pulmonary clinic. Stolz highlighted that two cases of interstitial lung disease (ILD) may appear similar from HRCT, showing lung opacities and interstitial reticulation, yet they can have dramatically different disease course and survival outcomes.

IN THIS pertinent session, which took place on the second day of the European Respiratory Society (ERS) International Congress 2022, in Barcelona, Spain, experts discussed the impact of crisis on both healthcare providers and patients. Chaired by Anita Simonds, Emeritus Professor of Respiratory and Sleep Medicine, Imperial College London, UK, and Arzu Yorgancıoğlu, Professor and Head of the Department of Pulmonology at Celal Bayar University, Turkey, the session saw experts and patient representatives share their experiences following the crisis of the Ukraine war.

Advances in technology in recent years increased the long-term survival rate of patients with chronic respiratory failure. As a result, the number of patients receiving long-term home mechanical ventilation (LTHV) support is increasing worldwide.1 The most important step in the management of patients with home mechanical ventilation (HMV) is to ensure adequate oxygenation and ventilation. Successful care at home requires the presence of trained caregivers and accessibility to medical devices and a care team.